TGM2 and cancer: Due to tTG’s capability to be i) recognized as autoantigen in not only intestinal but also systemic tissues including CNS, ii) to cause cerebral β-amyloid polymerization, and iii) to facilitate inflammation and cancer, it became an attractive drug target for a multitude of diseases [36,37,39,43].